Rebecca Flyckt, MD
- Division Chief, Reproductive Endocrinology and Infertility, UH Ahuja Medical Center
- Division Chief, Reproductive Endocrinology and Infertility, UH Cleveland Medical Center
- Associate Professor, CWRU School of Medicine
- Specialty: Reproductive Endocrinology, OB/GYN-General
Location:UH Fertility Center
1000 Auburn Dr
Beachwood, OH 44122
- Call: 216-285-5028
Biography: Rebecca Flyckt, MD
Certifications & Memberships
- Reproductive Endocrinology and Infertility - American Board of Obstetrics and Gynecology
- Obstetrics and Gynecology - American Board of Obstetrics and Gynecology
Fellowship | Reproductive Endocrinology
Reproductive Endocrinology - Cleveland Clinic (2010 - 2013)
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - UH Cleveland Medical Center (2006 - 2010)
Stanford University School Of Medicine (2001 - 2006)
University Of Michigan (1998)
Rebecca Flyckt, MD joined the University Hospitals Fertility Center as Division Director of Reproductive Endocrinology and Infertility in 2019. She is a nationally-known REI and reproductive surgeon with particular expertise in minimally invasive surgery. She was principal investigator in the clinical trial that resulted in the first live-birth from a uterine transplant using a deceased donor in the U.S. in 2019. She was also part of the surgical team that performed the first uterus transplant in the U.S. in 2016.
Her research interests include reproductive surgery, endometriosis and infertility, uterus transplant and fertility preservation and she has published over fifty peer-reviewed manuscripts in these areas. She is on the Practice Committee of the Society of Reproductive Surgeons of the American Society for Reproductive Medicine and an editorial board member for the Journal of Minimally Invasive Gynecology (JMIG) and Fertility and Sterility. She brings her significant research and clinical experiences and passion for surgery to her role as Site Director for the SRS Surgical Scholars Track. This unique training positions fellow to become leaders in the field of reproductive surgery.
Related Blog Articles
Now Offered at University Hospitals Cleveland Medical Center - Innovations in Obstetrics & gynecology | Winter 2023
Innovations in Obstetrics & Gynecology | Fall 2022
Clinical Trials Awareness Week is a week-long celebration recognizing our research investigators, study team members and research participants and their commitment to advancing science and discovery in medicine. All of whom have contributed to...
Reprogenomics holds the promise of early intervention on embryos and their environments, with an ultimate goal of reducing maternal and fetal morbidity and mortality. - Innovations in Obstetrics & Gynecology | Fall 2021
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Robert Cirino did not disclose any Outside Relationships with Industry.